Investors Research Corp’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.79K Sell
43
-2,315
-98% -$198K ﹤0.01% 633
2026
Q2
$182K Sell
2,358
-57
-2% -$4.16K 0.03% 279
2026
Q1
$158K Sell
2,415
-227
-9% -$16.9K 0.03% 290
2025
Q4
$209K Hold
2,642
– – 0.04% 287
2025
Q3
$193K Hold
2,642
– – 0.04% 304
2025
Q2
$200K Hold
2,642
– – 0.04% 302
2025
Q1
$201K Hold
2,642
– – 0.04% 292
2024
Q4
$175K Sell
2,642
-25
-0.9% -$1.75K 0.04% 314
2024
Q3
$186K Hold
2,667
– – 0.04% 317
2024
Q2
$141K Buy
+2,667
New +$162K 0.03% 357

Other funds holding SOLV

Investors Research Corp's SOLV Position: Q3 2026 in Review

Investors Research Corp reduced its Solventum (SOLV) stake by 98% in Q3 2026, selling an estimated $198K and leaving 43 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Investors Research Corp first reported a position in SOLV in Q2 2024 and has held it in 10 quarters since. The position peaked at $209K in Q4 2025. 31 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Investors Research Corp held 43 shares of Solventum worth $3.79K as of Q3 2026.
  • Investors Research Corp sold 2,315 Solventum shares in Q3 2026, an estimated $198K.
  • Solventum made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #633 holding.
  • Investors Research Corp first reported a position in Solventum in Q2 2024 and has held it in 10 quarters since.
  • Investors Research Corp's Solventum position peaked at $209K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.